Styrylacrylonitrile compounds for inhibition of vascular...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/165 (2006.01) A61K 31/137 (2006.01) A61K 31/216 (2006.01) A61K 31/277 (2006.01) A61K 31/662 (2006.01) A61P 17/00 (2006.01) A61P 19/08 (2006.01) A61P 27/02 (2006.01) A61P 31/22 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) A61P 37/06 (2006.01)

Patent

CA 2500385

This invention relates to therapeutic organic compounds and inhibition of secretion of vascular endothelial grown factor (VEGF) and its effects, including angiogenesis.

La présente invention concerne des composés organiques thérapeutiques ainsi que l'inhibition de la sécrétion du facteur de croissance endothélial vasculaire (VEGF), et de ses effets, notamment de l'angiogenèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Styrylacrylonitrile compounds for inhibition of vascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Styrylacrylonitrile compounds for inhibition of vascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Styrylacrylonitrile compounds for inhibition of vascular... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1437860

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.